Sponsor pipeline

Elion Therapeutics, Inc. clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 2

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT07215273	Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy	Invasive Mould Infection	Recruiting	2026-10-05

Get alerts when Elion Therapeutics, Inc.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.